Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chickenpox Vaccines”

279 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 279 results

Large-scale testing (Phase 3)Study completedNCT02329457
What this trial is testing

VZV Vaccine for Hematopoietic Stem Cell Transplantation

Who this might be right for
Varicella Zoster Infection
The University of Hong Kong 100
Not applicableNot Yet RecruitingNCT06364033
What this trial is testing

Biological and Clinical Efficacy of Shingrix in Patients With CLL

Who this might be right for
Chronic Lymphocytic LeukemiaSmall Lymphocytic LymphomaCLL-like MBL+1 more
Gruppo Italiano Malattie EMatologiche dell'Adulto 312
Large-scale testing (Phase 3)Study completedNCT02690207
What this trial is testing

Cross-vaccination Study of GSK Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine (GSK 1437173A) in Subjects Who Previously Received Placebo in ZOSTER-006 (NCT01165177) and ZOSTER-022 (NCT01165229) Studies.

Who this might be right for
Herpes Zoster
GlaxoSmithKline 8,687
Early research (Phase 1)Ended earlyNCT00005009
What this trial is testing

Evaluation of the Safety of Varivax® in Pediatric Renal Transplant Recipients

Who this might be right for
Kidney Transplant Recipients
National Institute of Allergy and Infectious Diseases (NIAID) 7
Not applicableWithdrawnNCT01738841
What this trial is testing

Safety Study of Measles-Mumps-Rubella-Varicella (MMRV) Vaccine, Priorix-Tetra™ in Children Living in the Philippines

Who this might be right for
MumpsRubellaMeasles+1 more
GlaxoSmithKline
Testing effectiveness (Phase 2)Study completedNCT02526745
What this trial is testing

Safety and Immunogenicity Study of Live Attenuated Vaccine Against Herpes Zoster in Chinese Adults Aged 50 Years and Older

Who this might be right for
Herpes Zoster
Beijing Chaoyang District Centre for Disease Control and Prevention 440
Post-approval studies (Phase 4)Study completedNCT01817270
What this trial is testing

Immunogenicity and Safety Study of 2 Doses of Live Attenuated Varicella Vaccine

Who this might be right for
Chickenpox
Changchun Keygen Biological Products Co., Ltd. 368
Large-scale testing (Phase 3)Study completedNCT04176939
What this trial is testing

Test GlaxoSmithKline's (GSK) Herpes Zoster (HZ) Subunit Vaccine's Long-term Immune Response in Previously Vaccinated Kidney Transplant Adults and Then to Test if 2 Additional Doses of the Vaccine Are Safe and Able to Generate an Immune Response

Who this might be right for
Herpes Zoster
GlaxoSmithKline 68
Testing effectiveness (Phase 2)Study completedNCT04072497
What this trial is testing

A Clinical Study of a Zoster Vaccine in Healthy Adults >= 40 Years

Who this might be right for
Herpes Zoster
Shanghai Institute Of Biological Products 522
Large-scale testing (Phase 3)Study completedNCT05219253
What this trial is testing

A Study on the Immune Response and Safety of a Vaccine Against Herpes Zoster in Adults Aged 50 Years and Older in India

Who this might be right for
Herpes Zoster
GlaxoSmithKline 288
Large-scale testing (Phase 3)Study completedNCT01229267
What this trial is testing

Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Participants Undergoing Hematopoietic Cell Transplants (HCTs) (V212-001)

Who this might be right for
Herpes Zoster
Merck Sharp & Dohme LLC 1,257
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06801509
What this trial is testing

Evaluate the Safety, Tolerability, and Immunogenicity of a Recombinant Herpes Zoster Vaccine

Who this might be right for
Herpes Zoster
Sinocelltech Ltd. 540
Post-approval studies (Phase 4)WithdrawnNCT02026089
What this trial is testing

Persistence of Varicella Immunity in Hospital Employees Receiving Varicella Vaccine

Who this might be right for
Persistence of Varicella Immunity
University of Colorado, Denver
Post-approval studies (Phase 4)Enrolling By InvitationNCT05095701
What this trial is testing

An Immunity Persistence Study of Live Attenuated Varicella Vaccine

Who this might be right for
Varicella
Sinovac (Dalian) Vaccine Technology Co., Ltd. 703
Testing effectiveness (Phase 2)Study completedNCT00802464
What this trial is testing

Immunogenicity and Safety Study of GSK Biologicals' Herpes Zoster Vaccine With Various Formulations in Adults >= 50 Years

Who this might be right for
Herpes Zoster
GlaxoSmithKline 410
Large-scale testing (Phase 3)Study completedNCT02979639
What this trial is testing

Study to Evaluate the Impact of Reactogenicity on Quality of Life (QoL), After Administration of GlaxoSmithKline (GSK) Biologicals' Candidate Herpes Zoster Subunit (HZ/su) Vaccine (GSK1437173A) in Adults ≥ 50 Years of Age

Who this might be right for
Herpes Zoster
GlaxoSmithKline 404
Large-scale testing (Phase 3)Study completedNCT03120364
What this trial is testing

Immunogenicity and Safety of NBP608 Compared to Zostavax in Healthy Adult Aged 50 and Over

Who this might be right for
Herpes Zoster
SK Chemicals Co., Ltd. 824
Not applicableStudy completedNCT01483378
What this trial is testing

Increasing Use of the Vaccine Against Herpes Zoster/Shingles at NYULMC and Bellevue Hospital

Who this might be right for
Herpes Zoster
NYU Langone Health 170
Not applicableStudy completedNCT03563183
What this trial is testing

Assess Frailty of Subjects During ZOSTER-006 and ZOSTER-022

Who this might be right for
Herpes Zoster
GlaxoSmithKline 26,976
Testing effectiveness (Phase 2)Study completedNCT05630846
What this trial is testing

A Study on the Immune Response and Safety of a Combined Measles, Mumps, Rubella, Chickenpox Vaccine Compared to a Marketed Combined Vaccine, Given to Healthy Children 4 to 6 Years of Age

Who this might be right for
Measles; Mumps; Rubella; ChickenpoxMeasles
GlaxoSmithKline 801
Load More Results